Global Biopsy Devises Market Size, Growth, Analysis, Trends, and Opportunities-2018

Summary:
A new market study, titled “Biopsy Devises Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023”, has been featured on WiseGuyReports.
Report Description:
Biopsy Devices Market 
Increase in the prevalence of various cancer diseases such as prostate, breast, and lung cancers, technological development of the biopsy devices, increase the adoption of integrated biopsy technologies, and lack of screening tests for the specific type of cancer are anticipated to drive the biopsy devices market over the forecast period. In addition, increase the awareness about the chronic diseases, rise in global geriatric population, increase in the preference for minimally invasive procedures, and growing importance of disease screening for early treatment expected to propel the biopsy devices market. However, a high cost of the biopsy devices, unfavourable reimbursement policies, stringent regulatory guidelines, and lack of skilled technicians might hamper the growth of Biopsy devices market.
The biopsy is a minimally invasive surgical process performed to remove the tissue from the body for the determination of presence or extent of diseases such as cancer and inflammatory conditions. Generally, the biopsy is carried by radiologists, surgeons, and interventional cardiologists to confirm the presence of disease. A biopsy can be carried for the majority of organs in the body with the aid of specific biopsy devices. The various types of biopsy devices include skin biopsy, shave biopsy, fine needle aspiration, excision and incision biopsy, and vacuum-assisted biopsy among others. Conventional biopsy devices are complimented with the advanced imaging technologies like stereotactic-guided biopsy, CT scan, MRI-guided, ultrasound-guided biopsy, and others. These devices are helping to perform the biopsies in critical areas such as liver, kidney, and lungs.
Biopsy devises market is segmented on the basis of device type, application, imaging technologies, and end user.
Based on the device type, biopsy devices market is segmented into the following:
Core biopsy devices
Core biopsy needles
Core biopsy guns
Needle-based biopsy devices
Vacuum-assisted biopsy devices
Needles
Guns
Aspiration biopsy needles
Others
Based on the application, biopsy devices market is segmented into the following:
Gastrointestinal biopsy
Lung
Liver
Breast biopsy
Gynaecological
Kidney
Others
Based on the imaging technologies, biopsy devices market is segmented into the following:
Ultrasound-guided biopsy
Stereotactic guided biopsy
CT scan
MRI guided biopsy
Others
Based on the end user, Biopsy devices market is segmented into the following:
Hospitals
Clinics
Diagnostic Centres
Biopsy devises market is growing at a significant CAGR due to increase in the prevalence of cancer around the globe. Technological advancements of biopsy devices and increase in the demand for biopsy devices in disease screening for early treatment propel the biopsy devices market. Acquisitions and mergers, collaborations, product and patent approvals, and product launches are key strategies followed by the players for increasing market revenue growth. For instance, in September 2014, Argon Medical Devices, Inc. acquired Promex Technologies, LLC for diversification of business segment into the soft-tissue biopsy devices. Similarly, in September 2015, MDxHealth acquired the NovioGendix for developing its product portfolio in the prostate cancer diagnosis. Furthermore, in January 2015, Intact Medical Corp. has received the FDA approval for its minimally invasive breast biopsy devices.
Geographically, Biopsy devices market is segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. The growth of North America in biopsy devices market is attributed to increase in R&D activities, technological advancements of biopsy devices, increase in the prevalence of cancer disease (As per National Cancer Institute, in 2016, about 1,685, 210 new cancer cases were diagnosed in the U.S. and approximately 595,690 people will die from cancer), and availability of skilled professionals expected to fuel the biopsy devices market in the region. Europe holds a major share owing to increase in the prevalence of cancer (As per WHO Europe statistics, in 2012, more than 3.7 Mn new cases and 1.9 Mn deaths occur each year due to cancer), rise in the healthcare expenditure, increase in the R&D activities, and rise in adoption of minimally invasive procedures are anticipated to drive the biopsy devices market in Europe region. Asia Pacific region is expected to exhibit significant growth over the forecast period due to increase in the geriatric population especially in Japan, China, and India, increase in the prevalence of various types of cancers, and rise in the medical tourism in Asia Pacific region might propel the biopsy devices market.
Some of the players in Biopsy devices market are Becton, Dickinson and Company (U.S.), Argon Medical Devices (U.S.), Cardinal Health, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Hologic, Inc. (U.S.), SmartTarget Ltd. (U.K.), MDxHealth (Belgium), and Intact Medical Corporation (U.S.) to name a few.
In August 2017, Hologic launched Bravera a breast biopsy system used for real-time breast biopsy and verification
In September 2016, SmartTarget Ltd launched its CE marked biopsy device used in the diagnosis of prostate cancer in U.K.
Table of Contents
  1. Executive Summary
  2. Global Biopsy Devices Market Introduction
  3. Global Biopsy Devices Market Dynamics
  4. Global Biopsy Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
  5. Global Biopsy Devices Market, By Device, 2012 – 2016 and Forecast, 2017 – 2023
  6. Global Biopsy Devices Market Forecast, By Application, 2012 – 2016 and Forecast, 2017 – 2023
  7. Global Biopsy Devices Market Forecast, By Imaging Technology, 2012 – 2016 and Forecast, 2017 – 2023
  8. Global Biopsy Devices Market Forecast, By End-User, 2012 – 2016 and Forecast, 2017 – 2023
  9. Global Biopsy Devices Market Forecast, By Region, 2012 – 2016 and Forecast, 2017 – 2023
  10. North America Biopsy Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
  11. Europe Biopsy Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
  12. Asia-Pacific Biopsy Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
  13. Latin America Biopsy Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
  14. Middle East and Africa Biopsy Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
  15. Competition Landscape
  16. Research Methodology
  17. Key Assumptions and Acronyms

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT                                                      
Ph: +1-646-845-9349 (US)                          
Ph: +44 208 133 9349 (UK) 

Comments

Popular posts from this blog

Report on Angola Telecoms, Mobile and Broadband Market Status, Market Size by Players, Regions, Type, Application and Forecast to 2021

Telecoms, Mobile and Broadband 2019-2023 Laos Market Survey Industry Key Players – Lao Telecom, Thaicom, ETL, Unitel, Lao Asia Telecom, Star Telecom, Viettel

Samoa Telecoms, Mobile and Broadband Market Research Report Forecast to 2022